Doxycycline Dosage for Soft Tissue Infections
For adult soft tissue infections, doxycycline should be dosed at 100 mg orally twice daily.
This dosing recommendation is consistently supported across multiple IDSA guidelines and FDA labeling for skin and soft tissue infections (SSTIs) 1, 2, 3.
Dosing Algorithm by Clinical Scenario
For Methicillin-Susceptible S. aureus (MSSA) SSTI
- Dose: 100 mg orally twice daily 1
- Duration: Typically 5-10 days depending on clinical response 2
- Note: Doxycycline is bacteriostatic with limited recent clinical experience but remains guideline-recommended 1
For Methicillin-Resistant S. aureus (MRSA) SSTI
- Dose: 100 mg orally twice daily 1, 2
- Duration: 5-10 days 4
- Context: Particularly appropriate for outpatient purulent SSTIs when MRSA is suspected 2
FDA-Approved Dosing Regimen
The FDA label specifies 3:
- Loading dose: 200 mg on day 1 (administered as 100 mg every 12 hours)
- Maintenance: 100 mg daily thereafter
- For severe infections: 100 mg every 12 hours throughout treatment
Important Clinical Considerations
The 2014 IDSA guidelines strongly recommend doxycycline as a first-line oral option for purulent SSTIs, particularly when MRSA is of concern 2. This represents the most recent and authoritative guidance available.
Key Caveats:
- Contraindications: Not recommended for children under 8 years of age due to tooth discoloration risk 1, 2
- Administration: Should be taken with adequate fluids to reduce esophageal irritation risk 3
- Food interaction: Absorption is NOT significantly affected by food or milk, so can be given with meals if gastric irritation occurs 3
- Renal impairment: No dose adjustment needed; doxycycline does not accumulate in renal insufficiency 3
Resistance Patterns
While doxycycline has "limited recent clinical experience" noted in older guidelines 1, recent data from 2024 demonstrates it remains effective. A propensity-matched study showed equivalent clinical failure rates (6%) compared to cephalexin for presumed streptococcal SSTIs, supporting its use in regions with low tetracycline resistance 5.
Comparative Effectiveness
The Taiwan MRSA guidelines 4 list doxycycline 100 mg orally twice daily as a recommended outpatient option alongside TMP-SMX and minocycline, with treatment duration of 5-10 days. This international consensus reinforces the standard twice-daily dosing.
Common Pitfall to Avoid
Do not use the once-daily maintenance dosing (100 mg daily) for active infections. While the FDA label mentions this as an option after the loading dose 3, the IDSA guidelines and clinical practice consistently recommend 100 mg twice daily for the full treatment course of SSTIs 1, 2. The once-daily dosing may be insufficient for adequate tissue penetration in soft tissue infections.